Nevro Corp (NVRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
Sales | 70,531 | 60,922 | 55,400 | 41,651 | 33,124 |
Cost of Goods | 21,692 | 19,235 | 18,842 | 15,664 | 12,771 |
Gross Profit | 48,839 | 41,687 | 36,558 | 25,987 | 20,353 |
Operating Expenses | 55,800 | 43,794 | 43,323 | 35,668 | 34,268 |
Operating Income | -6,269 | -1,872 | -5,923 | -9,017 | -13,144 |
Interest Expense | 2,399 | 2,381 | 972 | 642 | 639 |
Other Income | -574 | 815 | -1,626 | 705 | 192 |
Pre-tax Income | -9,242 | -3,438 | -8,521 | -8,954 | -13,591 |
Income Tax | 583 | 448 | 258 | 334 | 600 |
Net Income Continuous | -9,825 | -3,886 | -8,779 | -9,288 | -14,191 |
Net Income | $-9,825 | $-3,886 | $-8,779 | $-9,288 | $-14,191 |
EPS Basic Total Ops | -0.34 | -0.14 | -0.31 | -0.33 | -0.50 |
EPS Basic Continuous Ops | -0.34 | -0.14 | -0.31 | -0.33 | -0.50 |
EPS Diluted Total Ops | -0.34 | -0.14 | -0.31 | -0.33 | -0.50 |
EPS Diluted Continuous Ops | -0.34 | -0.14 | -0.31 | -0.33 | -0.50 |
EBITDA(a) | $-5,869 | $-1,347 | $-5,662 | $-8,717 | $-12,951 |